Kouji Maruyama

Shizuoka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Pro-gastrin-releasing peptide expression in Ewing sarcoma cells in vitro and in vivo demonstrates its availability as a valuable tumor marker.

Pro-gastrin-releasing peptide expression in Ewing sarcoma cells in vitro and in vivo demonstrates its availability as a valuable tumor marker.

Journal: Biomedical research (Tokyo, Japan)
Published: May 28, 2025

Impact of the PD-1/PD-L1 inhibitor SCL-1 on MDA-MB231 tumor growth in a humanized MHC-double knockout NOG mouse model.

Impact of the PD-1/PD-L1 inhibitor SCL-1 on MDA-MB231 tumor growth in a humanized MHC-double knockout NOG mouse model.

Journal: Scientific reports
Published: May 18, 2025

Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing.

Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing.

Journal: Scientific reports
Published: April 18, 2025

Subcellular localization of pro-gastrin releasing peptide in human Ewing sarcoma cell lines.

Subcellular localization of pro-gastrin releasing peptide in human Ewing sarcoma cell lines.

Journal: Medical molecular morphology
Published: November 11, 2024

In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models.

In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models.

Journal: In vivo (Athens, Greece)
Published: September 17, 2024

Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes.

Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes.

Journal: Scientific reports
Published: August 01, 2022

BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer.

BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer.

Journal: Molecular and cellular biochemistry
Published: September 14, 2020

Metabolic Profiling of Human Gastric Cancer Cells Treated With Salazosulfapyridine.

Metabolic Profiling of Human Gastric Cancer Cells Treated With Salazosulfapyridine.

Journal: Technology in cancer research & treatment
Published: July 28, 2020

Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Particles and Stimulation of Immune Cell Migration in vivo.

Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Particles and Stimulation of Immune Cell Migration in vivo.

Journal: Journal of innate immunity
Published: March 31, 2019

A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.

A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 23, 2017

Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients.

Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients.

Journal: Biomedical research (Tokyo, Japan)
Published: August 23, 2016

Effects of beta-tricalcium phosphate particles on primary cultured murine dendritic cells and macrophages.

Effects of beta-tricalcium phosphate particles on primary cultured murine dendritic cells and macrophages.

Journal: International immunopharmacology
Published: April 08, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026